Some patients taking interferon alfacon-1 have developed a drop in the number of white blood cells and platelets. If the number of these blood cells are too low, there is an increased risk of infection or bleeding. Contact your doctor immediately if you develop a fever, symptoms of an infection, or unusual bleeding or bruising.
Use caution when driving, operating machinery, or performing other hazardous activities. Interferon alfacon-1 may cause drowsiness, dizziness, or impaired alertness. If you experience drowsiness, dizziness, or impaired alertness, avoid these activities.Interferon alfacon-1 is a protein. Interferons are released in the body in response to viral infections. Interferons are important for fighting viruses in the body, regulating reproduction of cells, and regulating the immune system.
Interferon alfacon-1 is used to treat chronic hepatitis C.
Interferon alfacon-1 may also be used for purposes other than those listed in this medication guide.
Before using interferon alfacon-1, tell your doctor if you
a history of depression, suicidal thoughts, anxiety, drug or alcohol abuse, or another mental illness;
an active infection;
heart disease or history of a heart attack;
an autoimmune disorder such as rheumatoid arthritis, systemic lupus erythematosus (SLE), or psoriasis;
have a suppressed immune system or have received an organ transplant,
have diabetes,
have an eye disease,
have thyroid disease,
have bone marrow suppression, or
You may not be able to use interferon alfacon-1, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.
Interferon alfacon-1 is in the FDA pregnancy category C. This means that it is not known whether interferon alfacon-1 will be harmful to an unborn baby.![]() |
![]() |
